ICN Registers 4 Million Shares

ICN Pharmaceuticals Inc. registered more than 4 million shares of its common stock for possible sale by outside shareholders.

The Costa Mesa-based drug maker’s filing with the Securities and Exchange Commission will enable F. Hoffman-La Roche Ltd. to sell the 4.1-million shares it obtained last month in exchange for promissory notes issued when ICN bought worldwide marketing rights for a number of drugs.

In addition, ICN registered 6,959 shares of its stock issued to former owners of Gly-Derm Inc., a company ICN purchased last year.

ICN will not receive any proceeds if the sellers choose to unload their shares.